As SAFC continues to settle into 2012, there is plenty of planning and development going on across the global SAFC network. Leading into the first big tradeshow of the year, Informex 2012 in New Orleans, LA, SAFC has been focused on introducing a new line of products that take quality and security of supply chain to another level. Below, Dave Backer, SAFC Director of Business Development and Marketing, discusses what the PharmaGrade product portfolio, means for SAFC customers and why it is relevant to the market.
Archive for the ‘Supply Chain’ Category
SAFC’s Dave Backer Discusses the Full Line of SAFC PharmaGrade Products and Highlights the PharmaGrade MSX Product Capabilities
Friday, February 3rd, 2012SAFC Featured in the Informex 2012 Blog
Friday, January 27th, 2012SAFC Marketing Manager, Nick Johnson, talks about what SAFC is bringing to the “Big Easy” in 2012 and why Informex is a key annual event for SAFC. Please click here to read the full blog.
Rx-360 Gives Back to the Community and Makes an Impact on Quality at Informex 2012
Thursday, January 19th, 2012On Tuesday, February 14th, one day before the Informex 2012 show starts, Rx-360 will kick off their attendance at the event in New Orleans by partnering with Habitat for Humanity for one full day. Current and prospective members will be onsite in New Orleans and will work with the non-profit organization to help build a home for a family in need, as well as to promote the motto of “doing well while doing good”.
LIVE from CPhI Worldwide: SAFC Announces Safebridge Certification for the Verona, WI Facility
Wednesday, October 26th, 2011Manufacturing Chemist offers a view from the world’s largest pharmaceutical exhibition as SAFC announces Safebridge Certification for the Verona, Wisconsin facility that specializes in High Potency API manufacture (HPAPI).
Read the full story by clicking here.
Tom Beil Offers a Look into the Recent Rx-360 Presentation about the Benefits of Shared Audits for the Pharmaceutical Industry
Wednesday, October 12th, 2011In 2009, the International Pharmaceutical Supply Chain Consortium, Rx-360, was developed by volunteers from the Pharmaceutical and Biotech industry, including suppliers. The purpose of Rx-360 is to enhance the security of the pharmaceutical supply chain and to assure the quality and authenticity of the products moving through the supply chain. The consortium is a non-profit organization with a mission to create and monitor a global quality system that meets the expectations of industry and regulators to assure patient safety through the guarantee of product quality and authenticity throughout the supply chain.
As Vice President of Quality and Regulatory Affairs here at Sigma Aldrich, and as a board member of Rx-360, I have been very involved in setting up the guidelines for inspections and it has been gratifying to see that it is not just the industry that is taking note of what we have been doing – those in Government are, too.
Outsourcing Pharma speaks with SAFC Partner, Novozymes, about Supply Chain Management Strategy
Wednesday, October 5th, 2011In this piece, reporter Natalie Morrison talks with Luke Dimasi of Novozymes about the key to their supply chain management strategy and how the partnership with SAFC has supported this. Through this strategy, and the partnership with SAFC, Novozymes is able to focus on risk mitigation and management, redundancy planning and site management to successfully reach the end goal of adding value to customers. To read the story and see the full video, please click here.
Pharma Magazine Feature: From DNA to Harvest: A Platform Approach to Improved Bio-Production
Wednesday, September 28th, 2011The September/October issue of Pharma Magazine features an article authored by Bruce Lehr, SAFC Director of Development and Kevin Kayser, SAFC Associate Director of Cell Engineering which discusses using a platform development and manufacturing strategy to control operations across biopharmaceutical projects. The article further discusses SAFC’s ZFN (Zinc Finger Nuclease) technology which allows for the isolation of genes for modification. Please take a moment to read the full story here.
